María Elena González-González

Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidence.

Mariana Segovia‐Mendoza, María Elena González-González, David Barrera et al. · PubMed · 2015 · 135 citations

Medicine, Oncology, Pharmacology +17

Biological Effects of Recombinant Human Zona Pellucida Proteins on Sperm Function1

Pedro Caballero-Campo, Mayel Chirinos, Xue Jun Fan et al. · Biology of Reproduction · 2006 · 64 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells

Mariana Segovia‐Mendoza, María Elena González-González, Isela Martínez-Reza et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2014 · 62 citations

Medicine, Oncology, Pharmacology +13

Recombinant human ZP3-induced sperm acrosome reaction: Evidence for the involvement of T- and L-type voltage-gated calcium channels

Óscar Hernández‐Hernández, Mayel Chirinos, María Elena González-González et al. · Biochemical and Biophysical Research Communications · 2010 · 33 citations

Life Sciences, Physiology, Calcium Homeostasis +11

Human sperm degradation of zona pellucida proteins contributes to fertilization

Analilia Saldívar-Hernández, María Elena González-González, Ana A. Sánchez-Tusié et al. · Reproductive Biology and Endocrinology · 2015 · 25 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14